Literature DB >> 23998972

Epidemiology of reflux symptoms and GORD.

Jukka Ronkainen1, Lars Agréus.   

Abstract

Gastro-oesophageal reflux disease (GORD) occurs when reflux of gastric contents causes troublesome symptoms and/or complications (the Montreal definition). GORD is a common condition with a substantial economical burden to the community and it has a significant negative effect on health-related quality of life (HRQoL) while endoscopic findings like erosive oesophagitis per se seem to correlate badly with the experienced HRQoL. The prevalence of GORD varies over the world for unknown reasons, but genetic differences, difference in the Helicobacter pylori prevalence and life style factors like obesity might influence. The prevalence is lowest in East Asia (2.5-9.4%) and higher in Mid (7.6-19.4%) and Western Asia (12.5-27.6%). The highest population-based prevalence is reported from Europe (23.7%) and the US (28.8%). GORD seems to be fairly stable over time both in terms of symptoms and erosive oesophagitis, but the prevalence seems to be increasing both in Asia and in the West.
© 2013 Published by Elsevier Ltd.

Entities:  

Keywords:  Epidemiology; Erosive oesophagitis; Gastro-oesophageal reflux disease; Gastro-oesophageal reflux symptoms

Mesh:

Year:  2013        PMID: 23998972     DOI: 10.1016/j.bpg.2013.06.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  19 in total

1.  Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study).

Authors:  Núria Piqué; Marta Ponce; Vicente Garrigues; Luis Rodrigo; Félix Calvo; Carlos Martín de Argila; Fernando Borda; Antonio Naranjo; Javier Alcedo; María José Soria; Enrique Rey; Luis Bujanda; Javier P Gisbert; David Suarez; Xavier Calvet; Julio Ponce
Journal:  United European Gastroenterol J       Date:  2015-07-24       Impact factor: 4.623

2.  Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy.

Authors:  Salva Balbale; Andrew Gawron; Sherri L LaVela
Journal:  Patient Exp J       Date:  2018

3.  Gastroesophageal Reflux Management with the LINX® System for Gastroesophageal Reflux Disease Following Laparoscopic Sleeve Gastrectomy.

Authors:  Kenneth Desart; Georgios Rossidis; Michael Michel; Tamara Lux; Kfir Ben-David
Journal:  J Gastrointest Surg       Date:  2015-07-11       Impact factor: 3.452

4.  Development of quality measures for the care of patients with gastroesophageal reflux disease.

Authors:  Rena Yadlapati; Andrew J Gawron; Karl Bilimoria; Rajesh N Keswani; Kerry B Dunbar; Peter J Kahrilas; Philip Katz; Joel Richter; Felice Schnoll-Sussman; Nathaniel Soper; Marcelo F Vela; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2014-11-18       Impact factor: 11.382

5.  Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms.

Authors:  Yuan He; Zhi-Jun Duan; Cheng-Fang Wang; Yu-Shan Wei; Ming-Xu Cai
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-20       Impact factor: 3.168

6.  GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis.

Authors:  Heba Abdel-Aziz; Mathias Schneider; Winfried Neuhuber; Abdel Meguid Kassem; Saleem Khailah; Jürgen Müller; Hadeel Gamal Eldeen; Ahmed Khairy; Mohamed T Khayyal; Anastasiia Shcherbakova; Thomas Efferth; Gudrun Ulrich-Merzenich
Journal:  Mol Med       Date:  2016-05-09       Impact factor: 6.354

7.  Comparing the Areas of Interest in the Field of Functional Gastrointestinal Disorder and Neurogastroenterology and Motility Between the East and the West.

Authors:  Ju Yup Lee; Nayoung Kim; Gwang Ha Kim; Gi Hyun Kim
Journal:  J Neurogastroenterol Motil       Date:  2015-10-01       Impact factor: 4.924

8.  The effect of abdominal visceral fat, circulating inflammatory cytokines, and leptin levels on reflux esophagitis.

Authors:  Su Youn Nam; Il Ju Choi; Kum Hei Ryu; Bum Joon Park; Young-Woo Kim; Hyun Beom Kim; Jeong Seon Kim
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

Review 9.  Helicobacter pylori-Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies.

Authors:  Karen Robinson
Journal:  Diseases       Date:  2015-03-27

10.  Patient Reported Outcomes Following Laparoscopic Surgery for Benign Upper Gastrointestinal Disease.

Authors:  Gary Dobson; Richard Thompson; Andrew Kennedy
Journal:  Ulster Med J       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.